We are live on
!
Find out more
GP
GLR Partners Portfolio holdings
AUM
$215M
This Fund
S&P 500
This Quarter
Est. Return
+15.46%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$215M
AUM Growth
+$31.5M
(+17%)
Cap. Flow
+$10M
Cap. Flow
% of AUM
4.67%
Top 10 Holdings %
Top 10 Hldgs %
46.18%
Holding
118
New
17
Increased
42
Reduced
37
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$2.74M |
| 2 |
Arista Networks
ANET
|
+$1.68M |
| 3 |
Pacer US Cash Cows 100 ETF
COWZ
|
+$1.33M |
| 4 |
Invesco S&P 500 Quality ETF
SPHQ
|
+$899K |
| 5 |
WisdomTree US Quality Growth Fund
QGRW
|
+$529K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$1.58M |
| 2 |
Precigen
PGEN
|
+$1.18M |
| 3 |
Monolithic Power Systems
MPWR
|
+$448K |
| 4 |
Vanguard Morningstar Growth ETF
VUG
|
+$335K |
| 5 |
HCA Healthcare
HCA
|
+$313K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.28% |
| 2 | Communication Services | 6.12% |
| 3 | Industrials | 5.52% |
| 4 | Healthcare | 5.32% |
| 5 | Financials | 4.32% |
Similar funds
COA
KCM
KWA
PWM
RWM
NC
GCL
LF
GLR Partners's Q2 2026 Portfolio in Review
As of Q2 2026, GLR Partners held 118 positions worth $215M, up 17% from $183M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
GLR Partners deployed $10M of net new capital in Q2 2026, opening 17 new positions and adding to 42 existing holdings. Its largest new stake was Arista Networks: 10,705 shares worth $1.82M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 11% a quarter earlier, followed by Communication Services and Industrials.
On the sell side, the largest reduction was Precigen, an estimated $1.18M trimmed.
- GLR Partners's largest Q2 2026 buy was Arista Networks: 10,705 shares worth $1.82M.
- GLR Partners added most to State Street SPDR Bloomberg 1-3 Month T-Bill ETF in Q2 2026, an estimated $2.74M increase.
- GLR Partners's biggest Q2 2026 reduction was Precigen, cutting an estimated $1.18M.
- GLR Partners fully exited Vertex Pharmaceuticals in Q2 2026, selling an estimated $1.58M.
- GLR Partners's ten largest holdings make up 46% of its $215M portfolio in Q2 2026.
- GLR Partners opened 17 new positions and closed 7 in Q2 2026.
- GLR Partners's portfolio value rose 17% quarter-over-quarter to $215M.
Based on GLR Partners's 13F filing for Q2 2026, filed 27 Jul 2026.